Figure 2
From: Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer
Recurrence free survival in patient with total lymphocyte count >1,500 mm3 (0) and <1,500 mm3 (1).
Figure 2 | SpringerPlus